Chemed Co. (NYSE:CHE) Director Walter L. Krebs sold 2,910 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $430.41, for a total transaction of $1,252,493.10. Following the transaction, the director now owns 9,318 shares in the company, valued at $4,010,560.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

CHE stock traded down $9.51 during trading on Friday, reaching $423.96. 82,419 shares of the stock were exchanged, compared to its average volume of 120,300. The company has a current ratio of 0.81, a quick ratio of 0.78 and a debt-to-equity ratio of 0.25. The business has a 50 day moving average price of $397.93 and a 200-day moving average price of $346.46. Chemed Co. has a 1 year low of $260.03 and a 1 year high of $441.48. The firm has a market capitalization of $6.97 billion, a price-to-earnings ratio of 35.57, a P/E/G ratio of 2.98 and a beta of 1.14.

Chemed (NYSE:CHE) last issued its earnings results on Thursday, July 25th. The company reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.09 by $0.27. Chemed had a net margin of 10.94% and a return on equity of 35.63%. The company had revenue of $473.60 million for the quarter, compared to the consensus estimate of $471.72 million. During the same period in the previous year, the firm earned $2.81 earnings per share. Chemed’s quarterly revenue was up 7.2% compared to the same quarter last year. On average, research analysts anticipate that Chemed Co. will post 13.54 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 3rd. Shareholders of record on Monday, August 12th will be paid a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, August 9th. This is an increase from Chemed’s previous quarterly dividend of $0.30. This represents a $1.28 dividend on an annualized basis and a yield of 0.30%. Chemed’s payout ratio is 10.73%.

A number of research firms recently weighed in on CHE. Royal Bank of Canada boosted their price target on shares of Chemed to $405.00 and gave the stock a “sector perform” rating in a research report on Monday, July 29th. Zacks Investment Research lowered shares of Chemed from a “hold” rating to a “sell” rating in a research report on Thursday, May 9th. ValuEngine upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Friday, June 7th. Finally, Oppenheimer lifted their target price on shares of Chemed from $400.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $383.75.

A number of hedge funds have recently modified their holdings of CHE. BlackRock Inc. raised its stake in shares of Chemed by 2.5% in the 2nd quarter. BlackRock Inc. now owns 1,697,275 shares of the company’s stock valued at $612,445,000 after acquiring an additional 42,102 shares during the period. FMR LLC raised its stake in shares of Chemed by 27.0% in the 1st quarter. FMR LLC now owns 311,951 shares of the company’s stock valued at $99,847,000 after acquiring an additional 66,276 shares during the period. Investec Asset Management LTD raised its stake in shares of Chemed by 7.3% in the 2nd quarter. Investec Asset Management LTD now owns 269,948 shares of the company’s stock valued at $97,408,000 after acquiring an additional 18,449 shares during the period. Invesco Ltd. raised its stake in shares of Chemed by 7.4% in the 2nd quarter. Invesco Ltd. now owns 262,075 shares of the company’s stock valued at $94,567,000 after acquiring an additional 18,100 shares during the period. Finally, TimesSquare Capital Management LLC raised its stake in shares of Chemed by 27.9% in the 2nd quarter. TimesSquare Capital Management LLC now owns 217,000 shares of the company’s stock valued at $78,302,000 after acquiring an additional 47,300 shares during the period. 87.14% of the stock is currently owned by institutional investors.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Featured Story: What is a balanced fund?

Insider Buying and Selling by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.